Status:

COMPLETED

Effect of Rosuvastatin on Amnesia and Orientation Through Galveston Outcome Amnesia Test in Moderate Head Injury

Lead Sponsor:

Universidad Autonoma de San Luis Potosí

Collaborating Sponsors:

Hospital Central "Dr. Ignacio Morones Prieto"

AstraZeneca

Conditions:

Head Injury

Eligibility:

All Genders

16-50 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to determine whether rosuvastatin is effective in the management of moderate head injury by improving amnesia and orientation.

Detailed Description

The head injury is a frequent problem of health, which produces high morbid-mortality. Today is the main cause of death and disability between 18 and 40 years. In addition it originates expensive expe...

Eligibility Criteria

Inclusion

  • Man or woman \>16 and \<50 years with HI less 24 hours in progression and Glasgow between 9 y 12.
  • Man or woman \>16 and \<50 years with HI and Glasgow l3, with lesions in TC scan.
  • Acceptance of family to participate (first grade).

Exclusion

  • History of HI with disability
  • History of neurological or psychiatric disease with disability.
  • Administration 24 hrs previous of: fibrates, niacin, ciclosporin, azoles, macrolides, inhibitors of protease, nefazodone, verapamil, diltiazem,amiodarone.
  • Existence of systemic injury with life in compromise (massive bleeding, exposition of bone in fracture, hepatic or splenic laceration or in great vessels and shock).
  • Administration of THAM, mannitol, barbiturates, corticosteroids, scavengers of free radicals, inhibitors of lipidic peroxidation, indometacin, calcium antagonist, antagonists of neurotransmitters
  • Existence of intracranial lesion which needs surgery.
  • Lesions not classifiable or in brainstem.
  • Allergy to the drug.
  • Hepatopathy or myopathy (or) history of this, or clinical data of hepatic disease.
  • Management previous in other Hospital.
  • Pregnancy

Key Trial Info

Start Date :

July 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2007

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00329758

Start Date

July 1 2006

End Date

October 1 2007

Last Update

June 24 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Central "Dr. Ignacio Morones Prieto"

San Luis Potosí City, San Luis Potosí, Mexico, 78240